Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,301 | 112,704 | 125,728 | 107,990 | 128,664 |
| Receivables | 878 | 503 | 528 | 357 | 615 |
| TOTAL | $139,112 | $119,032 | $131,279 | $113,402 | $132,172 |
| Non-Current Assets | |||||
| PPE Net | 3,153 | 3,178 | 3,263 | 3,388 | 3,492 |
| Other Non-Current Assets | 8,185 | 6,968 | 7,345 | 7,714 | 8,076 |
| TOTAL | $11,338 | $10,146 | $10,608 | $11,102 | $11,568 |
| Total Assets | $150,450 | $129,178 | $141,887 | $124,504 | $143,740 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,125 | 12,425 | 9,864 | 14,291 | 13,458 |
| Accrued Expenses | 9,621 | 8,326 | 6,984 | 7,940 | 13,357 |
| TOTAL | $22,454 | $25,150 | $21,672 | $27,850 | $31,399 |
| Non-Current Liabilities | |||||
| Long Term Debt | 70,470 | 70,069 | 69,670 | 29,445 | 29,244 |
| Deferred Revenues | 2,034 | 2,769 | 3,237 | 4,075 | 3,081 |
| Other Non-Current Liabilities | 0 | 180 | 180 | 180 | 180 |
| TOTAL | $75,613 | $75,828 | $75,896 | $36,061 | $36,868 |
| Total Liabilities | $98,067 | $100,978 | $97,568 | $63,911 | $68,267 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,026 | 37,955 | 37,892 | 37,811 | 37,748 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -227,147 | -205,958 | -185,378 | -164,668 | -145,379 |
| TOTAL | $52,383 | $28,200 | $44,319 | $60,593 | $75,473 |
| Total Liabilities And Equity | $150,450 | $129,178 | $141,887 | $124,504 | $143,740 |